Judge Rejects Theranos Investors' Bid To Pause Settlements

By Jon Hill · August 15, 2017, 8:40 PM EDT

A proposed class of Theranos Inc. investors is moving forward with a securities fraud suit against the health technology startup after losing a bid to pause the company's settlements with Walgreen...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Colman et al v. Theranos, Inc. et al

Case Number

Court

California Northern

Nature of Suit

Other Fraud

Date Filed

November 28, 2016

Recent Articles By Jon

June 11, 2024
CFPB Floats Rule To Take Medical Debt Off Credit Reports
September 21, 2023
CFPB Plans Take Aim At Medical Debt Reporting, Data Brokers
July 07, 2023
CFPB-Backed Joint Inquiry Eyes Medical Credit Cards, Loans
June 08, 2023
CFPB Levies First Medical Debt Collector Fine Under Chopra
March 01, 2022
CFPB Chief Warns Of 'Weaponized' Medical Debt Reporting
July 28, 2021
Vaxart Suit Turns 'Mundane To Nefarious,' Del. Judge Told
August 06, 2020
Feds Charge 9 With $24M Virus Relief Loans Fraud Scheme
August 07, 2018
JP Morgan Can't Duck FINRA Arbitration, 3rd Circ. Says
March 20, 2018
Wells Fargo Reaches Confidential Deal Resolving ERISA Suit
March 12, 2018
Magellan Health Ducks Investor Suit Over AlphaCare Merger